Literature DB >> 11159612

Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening.

B Duncan1, G Hart, A Scoular, A Bigrigg.   

Abstract

OBJECTIVES: To investigate the psychosocial impact for women of a diagnosis of Chlamydia trachomatis and discuss the implications for the proposed UK chlamydia screening programme.
DESIGN: Qualitative study with semistructured interviews. Interview transcripts analysed to identify recurrent themes. PARTICIPANTS: Seventeen women with a current or recent diagnosis of chlamydia.
SETTING: A family planning clinic and a genitourinary medicine clinic in Glasgow.
RESULTS: Three themes were identified: perceptions of stigma associated with sexually transmitted infection, uncertainty about reproductive health after diagnosis, and anxieties regarding partner's reaction to diagnosis. Most women had not previously perceived sexually transmitted infections as personally relevant; this was a function of stereotypical beliefs about who was "at risk" of sexually transmitted infection. These beliefs were pervasive and negatively affected reactions to diagnosis and produced anxiety about disclosure of the condition to others (particularly sexual partners) and future reproductive morbidity. This anxiety, given the uncertain natural history of chlamydia, may prove difficult to dispel.
CONCLUSIONS: There are three primary areas of concern for women after a diagnosis of chlamydia which need to be examined in the proposed screening programme. Information provided should normalise and destigmatise chlamydial infection and positively promote genitourinary medicine services. Support services should be available because notification of partner can cause anxiety. Uncertainty about future reproductive morbidity may be inevitable; staff providing screening will require guidance in providing advice under such conditions.

Entities:  

Mesh:

Year:  2001        PMID: 11159612      PMCID: PMC26583          DOI: 10.1136/bmj.322.7280.195

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  9 in total

Review 1.  Questioning bioethics. AIDS, sexual ethics, and the duty to warn.

Authors:  D C Ainslie
Journal:  Hastings Cent Rep       Date:  1999 Sep-Oct       Impact factor: 2.683

Review 2.  Genital chlamydial infections: epidemiology and reproductive sequelae.

Authors:  W Cates; J N Wasserheit
Journal:  Am J Obstet Gynecol       Date:  1991-06       Impact factor: 8.661

3.  Qualitative research.

Authors:  K Buston; W Parry-Jones; M Livingston; A Bogan; S Wood
Journal:  Br J Psychiatry       Date:  1998-03       Impact factor: 9.319

4.  From the Centers for Disease Control and Prevention. Chlamydia trachomatis genital infections--United States, 1995.

Authors: 
Journal:  JAMA       Date:  1997-03-26       Impact factor: 56.272

5.  Why we need qualitative research.

Authors:  N Black
Journal:  J Epidemiol Community Health       Date:  1994-10       Impact factor: 3.710

6.  Knowledge of Chlamydia trachomatis infection in genitourinary medicine clinic attenders.

Authors:  D J Kellock; H Piercy; K E Rogstad
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

7.  Some peoples' psychological experiences of attending a sexual health clinic and having a sexually transmitted infection.

Authors:  H S Holgate; C Longman
Journal:  J R Soc Health       Date:  1998-04

8.  Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.

Authors:  D Scholes; A Stergachis; F E Heidrich; H Andrilla; K K Holmes; W E Stamm
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

9.  Women's experiences of repetitively contracting sexually transmitted diseases.

Authors:  N Redfern; S Hutchinson
Journal:  Health Care Women Int       Date:  1994 Sep-Oct
  9 in total
  48 in total

1.  Psychosocial impacts of chlamydia testing are important.

Authors:  C France; K Thomas; R Slack; N James
Journal:  BMJ       Date:  2001-05-19

2.  Emergency contraception from pharmacists misses opportunity.

Authors:  T Stammers
Journal:  BMJ       Date:  2001-05-19

3.  Attitudes about sexual disclosure and perceptions of stigma and shame.

Authors:  S D Cunningham; J Tschann; J E Gurvey; J D Fortenberry; J M Ellen
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

Review 4.  The application of qualitative research methods to the study of sexually transmitted infections.

Authors:  R Power
Journal:  Sex Transm Infect       Date:  2002-04       Impact factor: 3.519

5.  Current Issues in Screening for Chlamydia trachomatis.

Authors:  Robert L. Cook; Lars ØStergaard
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

6.  Near-patient testing will not improve the control of sexually transmitted infections.

Authors:  G L Dean
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

7.  "It feels good to be told that I'm all clear": patients' accounts of retesting following genital chlamydial infection.

Authors:  H Piercy
Journal:  Sex Transm Infect       Date:  2006-08       Impact factor: 3.519

8.  The cost effectiveness of opportunistic chlamydia screening in England.

Authors:  Elisabeth J Adams; Katherine M E Turner; W John Edmunds
Journal:  Sex Transm Infect       Date:  2007-07       Impact factor: 3.519

9.  Follow-up, treatment, and reinfection rates among asymptomatic chlamydia trachomatis cases in general practice.

Authors:  Irene G M van Valkengoed; Servaas A Morré; Adriaan J C van den Brule; Chris J L M Meijer; Lex M Bouter; Jacques Th M van Eijk; A Joan P Boeke
Journal:  Br J Gen Pract       Date:  2002-08       Impact factor: 5.386

10.  Opportunistic screening for genital chlamydial infection. II: prevalence among healthcare attenders, outcome, and evaluation of positive cases.

Authors:  J M Pimenta; M Catchpole; P A Rogers; J Hopwood; S Randall; H Mallinson; E Perkins; N Jackson; C Carlisle; G Hewitt; G Underhill; T Gleave; L McLean; A Ghosh; J Tobin; V Harindra
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.